• Mashup Score: 1

    The NCI’s Fiscal Year 2025 Professional Judgment Budget Proposal provides an overview of the funding needed to make progress against cancer and achieve the goal of ending cancer as we know it for all.

    Tweet Tweets with this article
    • NEW #BLOG: Dr. Diane Palmieri discusses NCI’s proposal to increase funding to support more meritorious #CancerResearch and spotlights one of the five scientific opportunities, the Cancer Research Data Ecosystem, where increased funding will spur advances. https://t.co/hqvks47W1C

  • Mashup Score: 3

    prostate cancer, urothelial carcinoma, bladder cancer, Antibody drug conjugates (ADCs), Enfortumab vedotin, HER2, Sacituzumab govitecan, ARX517 trial, PET imaging, breast cancer, prostate specific membrane antigen (PSMA), trophoblast cell-surface antigen 2 (TROP2), androgen targeting therapies, ARC-6 trial, Datopotamab deruxtecan, PETRA trial, disitamab vedotin, next generation prostate cancer treatment, new prostate cancer trials, B7H3.

    Tweet Tweets with this article
    • The next revelation in #ProstateCancer therapy? Antibody-drug conjugates. #COE #Blog Evan Yu, MD @fredhutch discusses promising research, paving the way for targeted therapies with enhanced efficacy and fewer side effects. #ReadNow details on UroToday > https://t.co/XegjExRsOq https://t.co/R1DcQ6GdvM

  • Mashup Score: 4
    Resources from FNLCR - 8 month(s) ago

    Learn about free resources for researchers from the Frederick National Laboratory for Cancer Research that are enabling breakthroughs in science.

    Tweet Tweets with this article
    • NEW #BLOG: @‌NCIDirector highlights resources available to researchers from @frednatlab. From cryo-electron #microscopy to the RAS Initiative, there are a variety of tools for the scientific community to propel research progress and enable breakthroughs. https://t.co/XCfMLU8zId

  • Mashup Score: 0
    Blog - NCQA - 9 month(s) ago

    NCQA Blog Stay up to date with NCQA and the latest in health care quality.

    Tweet Tweets with this article
    • Get the most from our available resources, and stay in tuned with NCQA's Blog for the latest news and updates: https://t.co/qwQoLhb85f #blog #healthcare #newsandupdates https://t.co/dFPRxiLqfy

  • Mashup Score: 0

    prostate cancer, urothelial carcinoma, bladder cancer, Antibody drug conjugates (ADCs), Enfortumab vedotin, HER2, Sacituzumab govitecan, ARX517 trial, PET imaging, breast cancer, prostate specific membrane antigen (PSMA), trophoblast cell-surface antigen 2 (TROP2), androgen targeting therapies, ARC-6 trial, Datopotamab deruxtecan, PETRA trial, disitamab vedotin, next generation prostate cancer…

    Tweet Tweets with this article
    • The next revelation in #ProstateCancer therapy? Antibody-drug conjugates. #COE #Blog Evan Yu, MD @fredhutch discusses promising research, paving the way for targeted therapies with enhanced efficacy and fewer side effects. #ReadNow details on UroToday > https://t.co/XegjExRsOq https://t.co/PQoQDoIDe4